CoreCap Advisors »

Protagenic Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $68 100 0.68

More positions owned by CoreCap Advisors

Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
State Street Technology Select Sector Spdr Etf Etf (XLK)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Invesco Qqq Trust Series I Etf (QQQ)
Schwab U.s. Small-cap Etf Etf (SCHA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Ishares Core S&p 500 Etf Etf (IVV)
State Street Spdr S&p 500 Etf Etf (SPY)
Amazon Stock (AMZN)

View all positions for CoreCap Advisors

Top funds holding Protagenic Therapeutics

DRW Holdings
FNY Investment Advisers
Citadel Advisors
Geode Capital Management
Raymond James Financial
Tower Research Capital
CoreCap Advisors
Advisor Group Holdings
CWM
Harbor Investment Advisory

View all funds holding Protagenic Therapeutics